Follicular thyroid cancer is the second most common type of thyroid carcinoma. Although this tumor is well differentiated, it grows invasively and tends to form metastases.
Local mass effects are the most frequent complications of FTC, since these tumors generally don't produce thyroid hormones. Consequently, patients present with an asymmetric, palpable mass below the larynx. Due to its close proximity to the latter, patients may be hoarse or dysphonic. They may also claim difficulties while ingesting solid food, less often while swallowing water. Dysphagia may be accompanied by dyspnea. If the tumor exerts pressure on the recurrent laryngeal nerve, the aforementioned symptoms tend to aggravate and the affected person may claim cough. FTC are usually not painful and grow slowly.
Anamnesis and physical examination should address the following issues:
- A possible familial history of thyroid cancer. As has been stated above, first-degree relatives of people diagnosed with this disease have higher risks of developing such a tumor themselves.
- Dietary habits. It should be evaluated whether a patient may suffer from iodine deficiency. If indicated, urinary iodine excretion needs to be assessed.
- Radiation exposure. Patients should be queried for possible radiation exposure at any point in their lifes since latency periods may span decades.
- Consistency and tenderness of the cervical mass. Thyroid carcinoma are usually firm. Pressure pain is uncommon.
- Abnormal findings in regional lymph nodes. PTC and MTC tend to spread via lymphatic vessels; FTC rather metastasize hematogenously into internal organs. However, lymph node involvement does not rule out FTC.
FTC patients may present metastases at the time of initial presentation. In some cases, symptoms triggered by functional impairment of lung, liver or bones may dominate the clinical picture. In this context, intolerance to exercise, upper abdominal pain, jaundice and pathologic fractures may be registered.
Entire Body System
METHODS: Among 854 patients who underwent thyroid surgery, the 198 patients who presented with thyroid nodules with a cytological diagnosis of follicular lesion were analyzed. [ncbi.nlm.nih.gov]
Both goiter and thrombus were completely replaced by follicular carcinoma. [ncbi.nlm.nih.gov]
Soft Tissue Swelling
Six of these patients presented with subcutaneous and soft tissue swellings, one presented with a lung mass, one with right breast swelling, one with lumbar vertebral lesion and one with left iliac bone involvement. [ncbi.nlm.nih.gov]
We report and discuss a unique case of a 70-year-old female patient presenting with arm pain, diagnosed with metastatic well-differentiated follicular carcinoma without a primary tumor in the thyroid. [ncbi.nlm.nih.gov]
Common modes of presentation of follicular thyroid carcinoma include a solitary thyroid nodule and cervical lymphadenopathy. We report four patients who presented with axial skeletal metastases rather than the usual neck lumps. [ncbi.nlm.nih.gov]
Clinically, differentiated thyroid cancer (DTC) commonly presents with a solitary thyroid nodule and/or cervical lymphadenopathy. [academic.oup.com]
There were no cervical lymphadenopathy or neck masses. [jpmsonline.com]
Particularly, the presence of cervical lymphadenopathy is an indirect sign of carcinoma in US diagnosis (23). Metastasis is often the initial symptom of FC, since patients usually remain asymptomatic in regards to thyroid function (1). [spandidos-publications.com]
Pain seldom is an early warning sign of thyroid cancer Other symptoms (eg, pain, stridor, vocal cord paralysis, hemoptysis, rapid enlargement) are rare – these symptoms can be caused by less serious problems At diagnosis, 10-15% of patients may have distant [thyroid.com.au]
Any patient with a thyroid lump and associated stridor should be referred for same day review by a secondary care specialist, as this may be due to recurrent laryngeal nerve involvement secondary to a thyroid carcinoma. [patient.info]
He had a tracheal deviation to the left. (a,b) Photographs of the 58-year-old man with metastatic follicular thyroid carcinoma showing multiple scalp and facial masses. [ncbi.nlm.nih.gov]
Malignant Pleural Effusion
Malignant pleural effusion (MPE) caused by metastatic differentiated thyroid carcinoma (DTC) is usually associated with a rapid fatal outcome and should be recognized as a grim prognostic indicator. [ncbi.nlm.nih.gov]
There was no history of dysphagia or change in voice. Patient gave negative history for any loss of appetite, gain or loss of weight, insomnia, palpitation, numbness, tingling, heat or cold intolerance. [thetrp.net]
There was no associated dyspnea, dysphagia, dysphonia or symptoms suggestive of hyperthyroidism. [ncbi.nlm.nih.gov]
Complications due to surgery and radio iodine therapy Hypothyroidism Dysphagia Vocal cord paralysis Hypoparathyroidism Sialoadenitis because radioiodine is taken up by the salivary glands Pulmonary fibrosis in patients with large lung metastases [slideshare.net]
Dysphagia may be accompanied by dyspnea. If the tumor exerts pressure on the recurrent laryngeal nerve, the aforementioned symptoms tend to aggravate and the affected person may claim cough. FTC are usually not painful and grow slowly. [symptoma.com]
Patients usually present with a rapidly growing mass in the neck, which may cause symptoms of obstruction such as dyspnoea and dysphagia. [patient.info]
Face, Head & Neck
masses, no shrinkage on TSH, family hx of thyroid carcinoma see: thyroid carcinoma (12 Dec 1998) acute follicular conjunctivitis An obsolete term for acute viral conjunctivitis. (05 Mar 2000) adenocarcinoma, follicular An adenocarcinoma of the thyroid [kmle.co.kr]
There were no cervical lymphadenopathy or neck masses. [jpmsonline.com]
Critical Essential Core Tested Community Questions (3) (M1.ON.4754) A 43-year-old female presents to her primary care physician complaining of a gradually enlarging neck mass. [step1.medbullets.com]
Before she discovered this oval-shaped tumor on her left scalp, there were no symptomatic signs, such as headache, pain, neck mass or chronic cough. Clinically, the scalp tumor measured about 3.8 1.0 cm with sharp margins and was movable. [edm.bioscientifica.com]
Discussion Thyroid cancers account for about 0.5 % of all cancers in men and 1.5 % of all cancers in women. 7 In Pakistan, thyroid cancer is responsible for about 1.2 % cases of all malignant tumours, with patients usually presenting with neck mass. 8,9 [jpma.org.pk]
Tumor-to-tumor metastases to the skull, presenting as a scalp mass, and thyroid follicular carcinoma presenting in that location are extremely rare. [ncbi.nlm.nih.gov]
Workup should aim at tumor staging and grading. Precise localization and size of the primary tumor can be evaluated sonographically. In general, FTC are solitary tumors that don't invade the capsule of thyroid lobes. In order to detect metastases, patients may be submitted to scintigraphic examination. Because this technique is based on enrichment of thyroid-like tissue with radio-labeled iodine, its sensitivity is rather low in case of carcinomas that don't produce thyroid hormones. Here, magnetic resonance imaging or computed tomography scans are indicated . About 10% of FTC patients present metastases at the time of first diagnosis.
Histopathological analysis of tissue samples is required to determine whether a thyroid tumor is benign or malignant, if it is indeed an FTC, and if the latter grows minimally or widely invasive. Although examination of fine needle aspirates may yield important information to this end - nuclear morphology, for instance, may reveal PTC - more extensive tissue samples are often required for a precise diagnosis and prognosis. As has been indicated above, differentiation between minimally or widely invasive growth of FTC may be particularly complicated. Therefore, surgical removal of neoplastic tissue is sometimes applied as a therapeutic and diagnostic measure, since conclusive results can much more easily be provided upon analysis of resected tissue.
Furthermore, serum concentrations of thyroid stimulating hormone (TSH), thyroglobulin, thyroxine (T4) and triiodothyronine (T3) should be measured. Hormone-producing thyroid cancer is associated with increased levels of thyroglobulin, T4 and T3, but concentrations of TSH are reduced due to autonomous activity. The latter may be confirmed by TSH suppression tests, but false-negative results are likely. A significant share of hormone-producing thyroid carcinomas does respond to TSH suppression. It has to be noted that these are not exclusion criteria for FTC, since this type of carcinoma most often does not produce thyroid hormones.
Evaluation of calcitonin and calcium levels is recommended and is particularly useful to differentiate FTC and MTC.
Surgical resection is the treatment of choice, but recommendations regarding the extent of tissue removal vary.
Some experts advise to limit surgery to lobectomy and isthmusectomy, unless widely invasive FTC has been diagnosed previously . Due to the aforementioned limitations of histopathological analysis of fine needle aspirates, this is rarely the case. Here, determination of the subtype of FTC is realized after surgery and only if a high degree of invasiveness is detected will the remaining part of the thyroid gland be removed. On the other hand, total thyroidectomy may be indicated for all patients diagnosed with FTC . This approach is justified by the fact that the majority of FTC patients do indeed suffer from widely invasive FTC and that this type of thyroid carcinoma is likely to metastasize early.
In any case, total thyroidectomy should be realized if the primary tumor measures more than 1 cm in diameter, if both lobes are affected, if invasive growth has been confirmed, if any metastasis has been detected, and if the patient is older than 40 years. Neck dissection and removal of lymph nodes as well as additional surgical procedures to resect metastases in internal organs may become necessary in such cases, too.
Post-surgical substitution of thyroid hormones is required.
Subsequently, patients should undergo radioactive iodine therapy to destroy possibly remaining tumor cells in the thyroid gland and in metastasis.
Prognosis of FTC is guarded since the disease is related to a mortality of 10-15%. Unfavorable prognostic factors are age over 45 years, size of the primary tumor over 2.5 cm in diameter, widely invasive FTC and histopathological anomalies as well as presence of metastases at the time of diagnosis .
The etiology of FTC is only partially understood. And although a variety of risk factors for thyroid cancer have been identified, most of them are primarily associated with PTC. Of course, it has to be assumed that both types of differentiated thyroid carcinoma share some causative factors. Little is known about specific triggers of FTC, though.
- FTC is generally related to iodine deficiency. In iodine-replete regions, the ratio between PTC and FTC is significantly higher than in iodine-deficient areas. In many countries, FTC incidence could be diminished by introducing iodized salt. Moreover, regional incidence of FTC has been proposed as an indicator of iodine deficiency prevalence .
- In general, exposure to radiation is considered a high risk factor for thyroid cancer. Incidence rates among people who survived the atomic bombings of Hiroshima and Nagasaki in Japan or the nuclear accident of Chernobyl, Ukraine, are very high. However, most tumors diagnosed in these patients correspond to PTC. It has been proposed that the age at exposure plays an important role in development of certain tumor types . Still, radiation of the neck does augment the risk for thyroid carcinoma and most likely, this also applies to FTC.
- Incidence of thyroid carcinoma is augmented among overweight and obese people . While the former only have a marginally increased risk for this type of cancer, findings regarding obese patients clearly indicate a correlation between body weight and likelihood of thyroid neoplasms.
- The results of several studies regarding the risk of PTC or FTC in first-degree relatives of patients who have already been diagnosed with these diseases imply a genetic component in thyroid cancer etiology .
In general, thyroid cancer is a rare disease. However, malignancies of the thyroid gland are the most common type of cancer that affects endocrine glands. Its annual incidence doesn't exceed 3 per 100,000 inhabitants, whereby less than 1 per 100,000 people are diagnosed with FTC. Retrospective analyses have shown a reduction of FTC incidence due to less frequent iodine deficiency, followed by a renewed increase of case numbers. The latter is generally ascribed to improved diagnostics.
Women are diagnosed with FTC up to four times more often than men.
FTC may develop at any age.
FTC usually develop as solitary tumors that cause local mass effects but that most often don't produce thyroid hormones. And while the thyroid gland consists of two connected lobes, both of which are surrounded by capsules consisting of taut connective tissue, most FTC are restricted to a single lobe and don't invade the capsule. FTC may be delimited by a pseudocapsule, but may still invade blood or lymphatic vessels. Thus, minimally invasive FTC and widely invasive FTC should be distinguished histopathologically, whereby the latter is more frequently observed. Unfortunately, even though the outcome may depend on invasiveness, clear diagnostic criteria for either type of FTC are not available .
According to the above described risk factors for FTC, the following measures may diminish the individual risk to develop this disease:
- Usage of iodized salt to assure an adequate supply with iodine
- Avoidance of radiation
- Maintenance of a healthy body weight
- Regular check-ups in patients who have a first-degree relative that was diagnosed with FTC
Thyroid cancer is a rather common type of malignant neoplasia, but benign tumors of the thyroid gland are more often observed.
Thyroid neoplasms may originate from distinct cell types, form well-demarcated tumors or grow invasively, and are thus associated with different outcomes. Generally, the following types of thyroid carcinoma are distinguished :
- Papillary thyroid carcinoma (PTC) is the most common thyroid cancer. About two out of three thyroid malignancies correspond to this type of cancer. Uncontrolled proliferation of thyroid follicular epithelial cells gives rise to this neoplasm, which usually metastasizes into regional lymph nodes.
- Follicular thyroid carcinoma (FTC) accounts for approximately 20% of thyroid malignancies. Just as PTC, this type of tumor derives from thyroid follicular epithelium and is well differentiated. However, PTC and FTC differ histopathologically as well as clinically. Here, hematogenous metastatic spread is much more common and thus, secondary tumors form in lung, liver or bones instead of lymph nodes. Of note, a mixed follicular-papillary thyroid carcinoma has been described .
- Medullary thyroid carcinoma (MTC) is diagnosed in a minor share of patients suffering from thyroid cancer. Contrary to PTC and FTC, MTC originates from calcitonin-producing thyroid cells (C cells). Tumor cells continue to secrete hormones and this fact is very helpful in diagnosing MTC. Both lymphogenic and hematogenous metastases are observed.
- Other types of thyroid cancer, e.g., anaplastic thyroid carcinoma or metastases of primary tumors located in other organs, are as rare as MTC.
The thyroid gland is located in the neck, below the larynx. It consists of two lobes that are connected by an isthmus. Thyroid tumors usually manifest in form of a palpable, firm, painless mass. Most of these tumors are benign, but malignant degeneration of thyroid cells may also occur. Dependent on the precise origin of such a malignant tumor, several types of thyroid cancer are distinguished. Follicular thyroid carcinoma (FTC) is the second most common one, with papillary thyroid carcinoma being the only type of thyroid cancer that is more frequently diagnosed.
Although FTC are generally well differentiated, they may grow invasively and form metastases in distant organs, namely in lung, liver and bones. An early diagnosis facilitates treatment and reduces the likelihood of metastatic spread. Thus, any mass suspicious of thyroid cancer should be thoroughly examined. Patients who suffer from thyroid cancer like FTC often claim difficulties while swallowing and breathing. Hoarseness and persistent cough may also be noted.
Diagnostic imaging techniques such as sonography and scintigraphy, in some cases also magnetic resonance imaging or computed tomography should be applied to assess localization and size of the primary tumor and to revise the whole body for possible metastases.
According to the results of these test, therapy will be planned: Thyroid cancer requires surgical removal of degenerated tissue. In order to avoid recurrence, the whole thyroid gland is removed in many cases. If metastases have been detected, further surgical interventions may become necessary.
Patients who underwent thyroidectomy need to replace thyroid hormones by medication.
- Schneider DF, Chen H. New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin. 2013; 63(6):374-394.
- Hanna AN, Michael CW, Jing X. Mixed medullary-follicular carcinoma of the thyroid: diagnostic dilemmas in fine-needle aspiration cytology. Diagn Cytopathol. 2011; 39(11):862-865.
- Kalk WJ, Sitas F, Patterson AC. Thyroid cancer in South Africa--an indicator of regional iodine deficiency. S Afr Med J. 1997; 87(6):735-738.
- Williams ED, Abrosimov A, Bogdanova T, et al. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer. 2004; 90(11):2219-2224.
- Schmid D, Ricci C, Behrens G, Leitzmann MF. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis. Obes Rev. 2015; 16(12):1042-1054.
- Handkiewcz-Junak D, Banasik T, Kolosza Z, et al. Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer -- a hospital based study. Neoplasma. 2006; 53(1):67-72.
- Ban EJ, Andrabi A, Grodski S, Yeung M, McLean C, Serpell J. Follicular thyroid cancer: minimally invasive tumours can give rise to metastases. ANZ J Surg. 2012; 82(3):136-139.
- DeGroot LJ, Kaplan EL, Shukla MS, Salti G, Straus FH. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab. 1995; 80(10):2946-2953.
- Summaria V, Rufini V, Mirk P, Costantini AM, Reale F, Maresca G. Diagnostic imaging of differentiated thyroid carcinoma. Rays. 2000; 25(2):177-190.
- Goffredo P, Cheung K, Roman SA, Sosa JA. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. Ann Surg Oncol. 2013; 20(3):767-772.
- Asari R, Koperek O, Scheuba C, et al. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg. 2009; 249(6):1023-1031.